๐ฌDeep Research
LMAT โ LeMaitre Vascular, Inc. ยท catalysts, narrative & risks
LeMaitre Vascular, Inc. (NASDAQ: LMAT) โ Company Profile
LeMaitre Vascular develops, manufactures, and markets medical devices and implants for vascular surgery (peripheral vascular disease), including vascular grafts, catheters, patches, valvulotomes, and carotid shunts, serving the Americas, Europe, the Middle East, Africa, and Asia Pacific [16]. Founded in 1986 and headquartered in Burlington, Massachusetts, it is led by chairman/CEO George W. LeMaitre [20]. A minor correction to our own calendar: the listing exchange is Nasdaq (NASDAQ:LMAT), not "NGM" [1], [9], [14], [20].
Recent Catalysts (last ~1โ3 months)
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ